2005 Annual Meeting | Clinical Trials in Neural Repair: Balancing Scientific Rigor and Patient Needs
| 06:45 AM - 07:00 AM |
Program Introduction
Michael E. Selzer, MD, PhD, FAAN |
|
| 06:45 AM - 08:30 AM |
Breakfast
|
|
| 07:00 AM - 07:30 AM |
Ex Vivo Gene Therapy for Alzheimer's Disease
Mark H. Tuszynski, MD, PhD, FAAN |
|
| 07:30 AM - 08:00 AM |
Rho-A Inhibition to Enhance Regeneration and Functional Recovery in Spinal Cord Injury
Lisa McKerracher, PhD |
|
| 08:00 AM - 08:30 AM |
Assessing Cell Transplantation Therapy in Parkinson's Disease
C. W. Olanow, MD |
|
| 08:30 AM - 08:45 AM |
Discussion
|
| C. W. Olanow, MD | Dr. Olanow has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Chevron/Syngenta. Dr. Olanow has stock in Clintrex Research Corporation. |
| Michael E. Selzer, MD, PhD, FAAN | No disclosure on file |
| Mark H. Tuszynski, MD, PhD, FAAN | No disclosure on file |
| Lisa McKerracher, PhD | No disclosure on file |